Cytta Introduces its EvrCare™ Remote Monitoring System Version 2.0
/
Date03 Jan 2017
San Francisco, Jan. 03, 2017 (GLOBE NEWSWIRE) — San Francisco, CA, January 3rd, 2017 –Cytta Corp. (OTCPINK:CYCA) Welcome to the year of Cytta. During the... Read More →
RedHill Biopharma Announces Exclusive U.S. Co-Promotion Agreement with Concordia for GI Drug Donnatal®
/
Date03 Jan 2017
RedHill and Concordia entered into an exclusive co-promotion agreement, granting RedHill certain U.S. promotion rights for Donnatal® Donnatal®1, Tablets and Elixir (syrup), is a prescription... Read More →
Dermira Initiates Phase 3 Clinical Program in Acne
/
Date03 Jan 2017
First patients dosed in Phase 3 program evaluating olumacostat glasaretil, a novel topical molecule, in patients with acne vulgaris Two Phase 3 trials expected to... Read More →
Akari Therapeutics Announces FDA Allowance of IND for Clinical Development of Coversin in PNH
/
Date03 Jan 2017
NEW YORK and LONDON, Jan. 03, 2017 (GLOBE NEWSWIRE) — Akari Therapeutics (NASDAQ:AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that the U.S. Food... Read More →
Novo Nordisk A/S – Status regarding Novo Nordisk's holding of its own shares (31 December 2016)
/
Date02 Jan 2017
20170102 – Holding of own shares_CA_UK.pdf Bagsværd, Denmark, 2 January 2017 – In continuation of the company’s announcements dated 5 August 2016 and 28... Read More →
Novo Nordisk A/S – Status vedrørende Novo Nordisks beholdning af egne aktier (31. december 2016)
/
Date02 Jan 2017
20170102 – Holding of own shares_CA_DK.pdf Bagsværd, 2017-01-02 – I forlængelse af selskabets meddelelser af 5. august 2016 og 28. oktober 2016 om planlagte aktietilbagekøbsprogrammer... Read More →
Home Healthcare Market Growth to exceed $391.41 Bn by 2021
/
Date02 Jan 2017
Sarasota, FL, Jan. 02, 2017 (GLOBE NEWSWIRE) — Zion Research has published a new report titled “Global Home Healthcare Market (Diagnostics and Monitoring Devices, Therapeutic... Read More →
Active pharmaceutical ingredient Market to register $213.84 Bn by 2021
/
Date02 Jan 2017
Sarasota, FL, Jan. 02, 2017 (GLOBE NEWSWIRE) — According to a new report published by Zion Market Research titled “Active Pharmaceutical Ingredients Market by API... Read More →
Esperite N.V.: Update on Financing
/
Date31 Dec 2016
PR Update on Financing Esperite.pdf Zutphen, The Netherlands – 31 December 2016 Esperite N.V. (Euronext: ESP, “Esperite” or “the Group”) announced during the year 2016 that it prepares... Read More →
BeiGene Announces First Patient Dosing in China Phase I Trial with Investigational Anti-PD-1 Monoclonal Antibody BGB-A317
/
Date30 Dec 2016
BEIJING, Dec. 30, 2016 (GLOBE NEWSWIRE) — BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company developing molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today... Read More →